Efficacy and tolerability of sumatriptan (10 and 20mg) in patients with moderate or severe migraine

Trial Profile

Efficacy and tolerability of sumatriptan (10 and 20mg) in patients with moderate or severe migraine

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2016

At a glance

  • Drugs Sumatriptan (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Nov 2010 New trial record
    • 29 Oct 2010 Results will be presented at the 2nd European Headache and Migraine Trust International, according to a OptiNose media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top